It has been shown that APOE4 carriers have impaired metabolism of plasma DHA, an omega-3 fatty acid partly responsible for BBB integrity, which is associated with behavioral and cognitive impairments [265]. The gene discussed is APOE; the disease is Cognitive impairment.